+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue



Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue



Journal of Pharmacology and Experimental Therapeutics 197(2): 263-271



para-Methoxyamphetamine (PMA), a known hallucinogen, is the most potent compound among methoxyamphetamines in disrupting behavior in rats. PMA, unlike d-amphetamine (A), did not induce stereotyped behavior and was less effective than A in stimulation of locomotor d-amphetamine-like effects, but ortho-methoxyamphetamine (OMA) was devoid of any locomotor stimulation. To investigate the reasons for the different behavioral effects caused by PMA, meta-methoxyamphetamine (MMA), OMA and A, a comparison was made among these drugs on the release and uptake of 3H-5-hydroxytryptamine (3H-5-HT), 3H-norepinephrine (3H-NE) and 3H-dopamine (3H-DA) in tissue slices of cerebral cortex and corpus striatum of rat brain. The potencies for the increased release of 3H-5-HT were found to be PMA greater than MMA greater than or equal to A greater than OMA in cerebral cortex of 3H-NE in cortex, A greater than or equal to PMA = MMA greater than OMA, and of 3H-DA in corpus striatum, A greater than MMA greater than PMA greater than or equal to OMA. The potencies for inhibiting the uptake of 3H-5-HT in cerebral cortex and corpus striatum were found to be PMA greater than MMA greater than A greater than OMA and of 3H-NE in cortex A greater than PMA greater than or equal to MMA greater than OMA, and 3H-DA in corpus striatum A greater than MMA greater than PMA greater than OMA. d-PMA is equipotent to l-PMA in increasing the release of 3H-5-HT but is more potent than l-PMA in blocking the uptake of 3H-5-HT. The high potency of PMA on increasing the release and inhibiting the uptake of 5-HT suggests than 5-HT may be involved in the production of hallucinogenic effects of PMA.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039614414

Download citation: RISBibTeXText

PMID: 1271280


Related references

Cation exchange--a common mechanism in the storage and release of biogenic amines stored in granules (vesicles)? I. Comparative studies on the uptake of sodium and biogenic amines by the weak cation (carboxyl) exchangers Amberlite IRC-50 and Sephadex C-50 and by biogenic (granule-enriched) materials in vitro. Acta Physiologica Scandinavica 119(3): 225-234, 1983

Comparison of the mono methoxy amphetamines on the uptake and release of biogenic amines in brain tissue. Pharmacologist 17(2): 259, 1975

Cation exchange a common mechanism in the storage and release of biogenic amines stored in granules vesicles 2. comparative studies on sodium induced release of biogenic amines from the synthetic weak cation exchangers amberlite irc 50 and duolite cs 100 and from biogenic granule enriched materials. Acta Physiologica Scandinavica 120(1): 87-98, 1984

Cation exchange--a common mechanism in the storage and release of biogenic amines stored in granules (vesicles)? II. Comparative studies on sodium-induced release of biogenic amines from the synthetic weak cation-exchangers Amberlite IRC-50 and duolite CS-100 and from biogenic (granule-enriched) materials. Acta Physiologica Scandinavica 120(1): 87-97, 1984

The effect of p substituted amphetamines on the uptake release and synthesis of brain biogenic amines. INT UNION PHARMACOL PROCEEDINGS OF THE INTERNATIONAL CONGRESS OF PHARMACOLOGY, 6TH ABSTRACT HELSINKI, FINLAND, 1975 632p ILLUS PERGAMON PRESS: OXFORD, ENGL ; NEW YORK, N Y , USA ISBN 0-08-021308-1: 164, 1977

Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices. European Journal of Pharmacology 45(4): 329-333, 1977

Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives. Journal of Pharmacology and Experimental Therapeutics 197(2): 253-262, 1976

Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for tritiated biogenic amines in rat brain tissue slices. European Journal of Pharmacology 45(4): 329-334, 1977

Effect of metabolic inhibitors and ouabain on amphetamine and potassium induced release of biogenic amines from isolated brain tissue. Int Union Pharmacoledings Of The International Congress Of Pharmacology, 6th. Abstract. Helsinki, Finland, . 632illus. Pergamon Press: Oxford, Engl.; New York, N.y., Usa. ISBN 0-08-021308-1: 422, 1977

Substituted amphetamine derivatives part 1 effect on uptake and release of biogenic mono amines and on mono amine oxidase in the mouse brain. Acta Pharmacologica et Toxicologica 41(4): 337-352, 1977

Biogenic amines and release factors. Studies on the effect of biogenic amines on the hypothalamic production of gonadotrophin release factors in vivo and in vitro. South African Medical Journal 46(24): 787-791, 1972

Effect of metabolic inhibitors and ouabain on amphetamine induced and potassium induced release of biogenic amines from isolated brain tissue. Biochemical Pharmacology 27(4): 511-516, 1978

Uptake and release of biogenic amines in "artificial granules". Acta Pharmacologica et Toxicologica 25: Suppl 4:31, 1967

The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue. Journal of Pharmacology and Experimental Therapeutics 189(1): 110-118, 1974

Mechanisms of transport for the uptake and release of biogenic amines in nerve endings. Advances in Experimental Medicine and Biology 69: 291-305, 1976